Clinical Trials Directory

Trials / Completed

CompletedNCT00868842

Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis

Open-label, Single-center Study of Whether Oral Penicillin Desensitization of Healthy Sensitive Subjects Results in Allergen Cross-desensitization of Mast Cells by Skin Testing and Desensitization of Peripheral Blood Basophils.

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This is an open-label, single-center study of whether oral penicillin desensitization of healthy sensitive subjects results in allergen cross-desensitization of mast cells by skin testing and desensitization of peripheral blood basophils. The primary endpoint(s) will be PC3 prick skin test values to penicillin, aeroallergen(s) and codeine. Secondary endpoints will be levels of Syk in purified basophils determined by flow cytometry (mean fluorescence intensity) and basophil degranulation (% tryptase release) to anti-FcåRI and to calcium ionophore.

Conditions

Timeline

Start date
2009-01-01
Primary completion
2012-05-01
Completion
2012-06-01
First posted
2009-03-25
Last updated
2014-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00868842. Inclusion in this directory is not an endorsement.